Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life‐threatening arrhythmia.

Detalles Bibliográficos
Autores principales: Nordkin, Irina, Levinas, Tatyana, Rosenfeld, Inna, Halabi, Majdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813084/
https://www.ncbi.nlm.nih.gov/pubmed/33489188
http://dx.doi.org/10.1002/ccr3.3539
_version_ 1783637788210495488
author Nordkin, Irina
Levinas, Tatyana
Rosenfeld, Inna
Halabi, Majdi
author_facet Nordkin, Irina
Levinas, Tatyana
Rosenfeld, Inna
Halabi, Majdi
author_sort Nordkin, Irina
collection PubMed
description Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life‐threatening arrhythmia.
format Online
Article
Text
id pubmed-7813084
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78130842021-01-22 Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation Nordkin, Irina Levinas, Tatyana Rosenfeld, Inna Halabi, Majdi Clin Case Rep Case Reports Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life‐threatening arrhythmia. John Wiley and Sons Inc. 2020-11-19 /pmc/articles/PMC7813084/ /pubmed/33489188 http://dx.doi.org/10.1002/ccr3.3539 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Nordkin, Irina
Levinas, Tatyana
Rosenfeld, Inna
Halabi, Majdi
Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
title Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
title_full Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
title_fullStr Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
title_full_unstemmed Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
title_short Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
title_sort torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813084/
https://www.ncbi.nlm.nih.gov/pubmed/33489188
http://dx.doi.org/10.1002/ccr3.3539
work_keys_str_mv AT nordkinirina torsadesdepointesafterprolongedintravenousamiodaronetherapyforatrialfibrillation
AT levinastatyana torsadesdepointesafterprolongedintravenousamiodaronetherapyforatrialfibrillation
AT rosenfeldinna torsadesdepointesafterprolongedintravenousamiodaronetherapyforatrialfibrillation
AT halabimajdi torsadesdepointesafterprolongedintravenousamiodaronetherapyforatrialfibrillation

Ejemplares similares